16.11.2014 Views

South African Clinical Laboratory Products Markets - Growth ...

South African Clinical Laboratory Products Markets - Growth ...

South African Clinical Laboratory Products Markets - Growth ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>South</strong> <strong>African</strong> <strong>Clinical</strong> <strong>Laboratory</strong><br />

<strong>Products</strong> <strong>Markets</strong><br />

Healthcare<br />

M22B-55<br />

Published: 30 April 2008<br />

1


Background to Study Slide 3<br />

Research Aims and Objectives Slide 5<br />

Scope of Research and Respondent Scope Slide 7<br />

Research Deliverables Slide 10<br />

Methodology followed Slide 15<br />

Benefits of Research Slide 17<br />

Frost & Sullivan Company Information and Contacts Slide 19<br />

Content


Background to Study<br />

The <strong>South</strong> <strong>African</strong> clinical laboratory products markets are in late- to mature growth phase. <strong>Clinical</strong><br />

chemistry- and immunoassay analysers are the largest contributors to revenue income in this<br />

market, followed by haematology analysers. Revenue income from urinalysis and coagulation<br />

systems are substantially lower.<br />

Technology trends followed in private laboratories indicate the use and implementation of integrated<br />

systems and consolidated workstations, while public laboratories still make use of stand-alone<br />

automated analysers. It is expected that this trend would drive the future market although growth<br />

will decrease over the forecast period.<br />

The market size for clinical laboratory products was estimated to be $83.9 million with a CAGR of<br />

4.1% from 2007 to 2013 to reach $111.2 million in 2013.<br />

3


Background to Study Slide 3<br />

Research Aims and Objectives Slide 5<br />

Scope of Research and Respondent Scope Slide 7<br />

Research Deliverables Slide 10<br />

Methodology followed Slide 15<br />

Benefits of Research Slide 17<br />

Frost & Sullivan Company Information and Contacts Slide 19<br />

Content


Research Aims and Objectives<br />

Population, economic and healthcare metrics<br />

A<br />

This report provides a strategic<br />

assessment of the healthcare industry<br />

of <strong>South</strong> Africa with a strong focus on<br />

the clinical laboratory products<br />

market. Key issues researched<br />

include:<br />

The healthcare regulatory environment<br />

B<br />

Market drivers, restraints and challenges faced in<br />

the clinical laboratory products markets<br />

C<br />

Market shares, market sizes and growth forecasts<br />

for the clinical laboratory products markets<br />

D<br />

Key success factors and recommendations within<br />

the clinical laboratory products markets<br />

E<br />

.<br />

5


Background to Study Slide 3<br />

Research Aims and Objectives Slide 5<br />

Scope of Research and Respondent Scope Slide 7<br />

Research Deliverables Slide 10<br />

Methodology followed Slide 15<br />

Benefits of Research Slide 17<br />

Frost & Sullivan Company Information and Contacts Slide 19<br />

Content


Scope of Research<br />

<strong>South</strong> <strong>African</strong> Advanced Wound Care Market<br />

MARKET SEGMENTATION:<br />

• <strong>Clinical</strong> Chemistry Analysers<br />

• Immunochemistry Analysers<br />

• Haematology Analysers<br />

• Urinalysis<br />

• Coagulation<br />

GEOGRAPHIC SCOPE<br />

• <strong>South</strong> Africa<br />

END-USER SEGMENTATION:<br />

• Private Laboratories<br />

• Public Laboratories<br />

7


Respondent Scope<br />

For Market Engineering research, Frost & Sullivan utilises tried and tested marketing techniques to provide<br />

structure to the research and an easy format to compare results across different countries, markets and over<br />

time.<br />

This project was carried out using primary research (telephone or face-to-face interviews) and secondary<br />

(published and online material) as the principle methods of data gathering. The focus of the interviews for this<br />

project were primarily the respondent types outlined in the figure below.<br />

Organisation Type Target Designations Type of Information<br />

<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong><br />

Manufacturers and Suppliers<br />

Marketing Managers, Sales Directors<br />

Business Development Managers,<br />

Operations Directors,<br />

Market Demand Volumes, Key Competitive<br />

Issues, Strategic Approaches, <strong>Products</strong>, Etc.<br />

<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong><br />

End-Users<br />

Private and Public <strong>Clinical</strong> Laboratories<br />

Type of equipment, volumes of tests, type of<br />

tests, Etc.<br />

Associations / Regulatory / Other<br />

Chairman, CEO, MD, Policy Directors,<br />

Departmental Managers, Industry<br />

Experts / Consultants<br />

Industry Data, Expected Market Developments,<br />

Supplier Information, Regulatory Environment,<br />

Challenges to Suppliers, Import / Export<br />

Controls<br />

8


Background to Study Slide 3<br />

Research Aims and Objectives Slide 5<br />

Scope of Research and Respondent Scope Slide 7<br />

Research Deliverables Slide 10<br />

Methodology followed Slide 15<br />

Benefits of Research Slide 17<br />

Frost & Sullivan Company Information and Contacts Slide 19<br />

Content


Research Deliverables<br />

An analysis of <strong>South</strong> Africa was carried out<br />

containing the following sections<br />

• Market engineering measurements<br />

• Country overview<br />

• Healthcare overview<br />

• Thorough country PESTLE analysis<br />

• <strong>Clinical</strong> laboratory products drivers,<br />

challenges and restraints<br />

• SA clinical laboratory products market size<br />

and growth forecasts<br />

• SA healthcare industry SWOT analysis<br />

• Key success factors for <strong>South</strong> Africa<br />

• Healthcare industry contact details<br />

R e v e n u e s ($ M illio n )<br />

<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong> Market: Revenue by<br />

Product Class (<strong>South</strong> Africa), 2007<br />

35.0<br />

30.0<br />

25.0<br />

20.0<br />

15.0<br />

10.0<br />

5.0<br />

0.0<br />

26.7<br />

33.2<br />

13.4<br />

Immunochemistry Chemistry Haematology Coagulation Urinalysis<br />

Product Class<br />

7.0<br />

3.8<br />

10


Research Deliverables<br />

There are 1 326 clinical laboratories in <strong>South</strong> Africa.<br />

The National Health <strong>Laboratory</strong> Services (NHLS) –<br />

the public health service provider – comprise 250<br />

(18.9%) of the total laboratories and can be<br />

accessed nationwide.<br />

The largest private laboratory group (based on<br />

number of laboratories) – Lancet – comprises 188<br />

(14.2%) of the total laboratories while Ampath has<br />

a total of 150 (11.3%), and Pathcare 69 (5.2%).<br />

Integrated systems and the consolidation of<br />

workstations are in infancy stage and it is expected<br />

that this trend will drive the long-term growth of this<br />

market.<br />

Future growth in this market will depend greatly on<br />

the expansion of current laboratories and the<br />

founding of new laboratories, if patient volumes<br />

demand this.<br />

The replacement of current systems and<br />

incorporation of new systems are another area that<br />

will increase growth.<br />

Key Industry Challenges:<br />

Health insurance<br />

<strong>Growth</strong> expectation<br />

Key Market Drivers:<br />

Preventative disease management<br />

ARV rollout<br />

Key Market Restraints:<br />

IT infrastructure<br />

Government tenders<br />

11


Research Deliverables<br />

<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong> Market: Manufacturer Market<br />

Share Analysis (<strong>South</strong> Africa), 2007<br />

23%<br />

11%<br />

21%<br />

22%<br />

23%<br />

SWOT analysis highlighted the following:<br />

STRENGTHS:<br />

Well developed market<br />

High patient demand<br />

WEAKNESSES:<br />

Skilled staff<br />

Energy crisis<br />

OPPORTUNITIES:<br />

Integration<br />

Replacement<br />

THREATS:<br />

Medical aid reimbursement<br />

Mature market<br />

Abbott Roche Beckman Coulter Siemens Other (BioRad, Scientific Group)<br />

12


Research Deliverables<br />

<strong>Clinical</strong> <strong>Laboratory</strong> <strong>Products</strong> <strong>Markets</strong>: Revenue and <strong>Growth</strong> Forecasts (<strong>South</strong> Africa), 2007<br />

120.0<br />

7.0%<br />

100.0<br />

6.0%<br />

Revenues ($ Million)<br />

80.0<br />

60.0<br />

40.0<br />

20.0<br />

5.0%<br />

4.0%<br />

3.0%<br />

2.0%<br />

1.0%<br />

Revenue <strong>Growth</strong> Rate (%)<br />

0.0<br />

2007 2008 2009 2010 2011 2012 2013<br />

Year<br />

0.0%<br />

Revenue<br />

Revenue <strong>Growth</strong> Rate<br />

13


Background to Study Slide 3<br />

Research Aims and Objectives Slide 5<br />

Scope of Research and Respondent Scope Slide 7<br />

Research Deliverables Slide 10<br />

Methodology followed Slide 16<br />

Benefits of Research Slide 18<br />

Frost & Sullivan Company Information and Contacts Slide 20<br />

Content


Methodology Followed<br />

This Research Service provides a strategic overview of the<br />

<strong>South</strong> <strong>African</strong> Healthcare industry and follows the principle of<br />

Frost & Sullivan's Market Engineering research methodology.<br />

This measurement-based methodology focuses on market<br />

measurement, analysis, forecasting, strategy development and<br />

monitoring.<br />

•The base year of 2006 was used for this research and a<br />

forecast period of seven years {from 2006} until 2012 was<br />

projected.<br />

Frost & Sullivan’s<br />

Market Engineering Research Methodology<br />

This study is based on thorough secondary and primary research principles. Extensive interviews were<br />

conducted with top level management of advanced wound care manufacturers and suppliers. Regulatory<br />

bodies also provided key market information allowing for a thorough, top-down analysis of the healthcare<br />

industry in <strong>South</strong> Africa.<br />

15


Background to Study Slide 3<br />

Research Aims and Objectives Slide 5<br />

Scope of Research and Respondent Scope Slide 7<br />

Research Deliverables Slide 10<br />

Methodology followed Slide 15<br />

Benefits of Research Slide 18<br />

Frost & Sullivan Company Information and Contacts Slide 20<br />

Content


Benefits of Research<br />

Provides excellent analysis of the external factors effecting the healthcare industry in <strong>South</strong> Africa<br />

Analysis of key market<br />

trends<br />

8<br />

1<br />

2<br />

Latest advanced wound<br />

care market revenue figures<br />

and forecasts<br />

Unique country risk rating<br />

using PESTLE data<br />

7<br />

Research<br />

Benefits<br />

3<br />

Leading advanced wound<br />

care manufacturers market<br />

share and revenue figures<br />

Thorough analysis of the<br />

regulatory environment<br />

for advanced wound care<br />

in <strong>South</strong> Africa<br />

6<br />

5<br />

Thorough comparison between<br />

public and private sector of<br />

<strong>South</strong> Africa with relevance to<br />

advanced wound care<br />

4<br />

Key market drivers,<br />

restraints and challenges<br />

for advanced wound care<br />

17


Background to Study Slide 3<br />

Research Aims and Objectives Slide 5<br />

Scope of Research and Respondent Scope Slide 7<br />

Research Deliverables Slide 10<br />

Methodology followed Slide 16<br />

Benefits of Research Slide 17<br />

Frost & Sullivan Contacts Slide 19<br />

Content


Frost & Sullivan Contacts<br />

Phil Howarth<br />

Operations Director<br />

Frost & Sullivan<br />

+27 21 680 3269<br />

phil.howarth@frost.com<br />

Keith Schlagbauer<br />

Practise Director<br />

Healthcare<br />

+27 21 680 3276<br />

keith.schlagbauer@frost.com<br />

Kate Howarth<br />

Sales Manager<br />

Frost & Sullivan<br />

+27 21 680 3261<br />

kate.howarth@frost.com<br />

Lizelle Wentzel<br />

Research Analyst<br />

Healthcare<br />

+27 21 680 3284<br />

lizelle.wentzel@frost.com<br />

19

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!